Additionally, it also reversed the multidrug resistance (MDR) by inhibiting the P-glycoprotein (P-gp) and MRP1 in L1210 (human MDR1 gene-transfected mouse lymphoma cells) and MDA-MB-231 (human breast cancer cells) [197]. Here, ABCB1 is linked to breast carcinoma.